We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Highlights: Phase I trial agreement with leading clinical research organization Human safety and tolerability study to assess infusion of RECCE® 327 in 40 healthy subjects as a single ascending...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.02 | -4.16666666667 | 0.48 | 0.49 | 0.45 | 154021 | 0.47333247 | DE |
4 | -0.01 | -2.12765957447 | 0.47 | 0.5 | 0.45 | 72629 | 0.47566549 | DE |
12 | -0.015 | -3.15789473684 | 0.475 | 0.55 | 0.38 | 141453 | 0.47188089 | DE |
26 | 0 | 0 | 0.46 | 0.57 | 0.38 | 142591 | 0.48934951 | DE |
52 | -0.05 | -9.80392156863 | 0.51 | 0.695 | 0.38 | 158357 | 0.49266048 | DE |
156 | -0.78 | -62.9032258065 | 1.24 | 1.27 | 0.38 | 140337 | 0.59601949 | DE |
260 | 0.11 | 31.4285714286 | 0.35 | 1.875 | 0.21 | 237445 | 0.80556568 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions